Skip to content

Artivion AORT EV / EBITDA

EV / EBITDA at other companies

Abbott logo
AbbottABT
18.9×-4.1×
Edwards Lifesciences logo
Edwards LifesciencesEW
29.5×+4.1×
LeMaitre Vascular logo
LeMaitre VascularLMAT
29.7×-0.3×
Medtronic logo
MedtronicMDT
13.9×-1.5×
ITG
Integer HoldingsITGR
13×-3.4×
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.2×-10.5×

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.1B-22.7%
Enterprise value$1.3B-25.5%
P/E94.1×
P/S2.4×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Calculated from Artivion’s reported figures.

Based on the most recent quarter.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's EV / EBITDA?
Artivion (AORT) reported EV / EBITDA of 32.2× in Q1 2026.
How has Artivion's EV / EBITDA changed year-over-year?
Artivion's EV / EBITDA decreased by 6.5% year-over-year, from 34.4× to 32.2×.
What is the long-term trend for Artivion's EV / EBITDA?
Over 5 years (2020 to 2025), Artivion's EV / EBITDA has grown at a -3.9% compound annual growth rate (CAGR), from 51.1× to 41.9×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.